Khard Biochem Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 M
- Revenue Growth 1764.10%
- Profit Growth -96.88%
- Ebitda 108.38%
- Net Worth 1.80%
- Total Assets 138.52%
About Khard Biochem
Khard Biochem Private Limited (KBPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 October 2010 and has a history of 14 years and three months. Its registered office is in Jhansi, Uttar Pradesh, India.
The Corporate was formerly known as Lifecare Medico Trade India Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.00 M.
Aneeta Gupta and Suryansh Gupta serve as directors at the Company.
Company Details
-
Location
Jhansi, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U36912UP2010PTC042355
-
Company No.
042355
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Oct 2010
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Khard Biochem?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Aneeta Gupta | Director | 17-Nov-2020 | Current |
Suryansh Gupta | Additional Director | 28-Mar-2020 | Current |
Financial Performance of Khard Biochem.
Khard Biochem Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 1764.1% increase. The company also saw a substantial fall in profitability, with a 96.88% decrease in profit. The company's net worth moved up by a moderate rise of 1.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Khard Biochem?
In 2021, Khard Biochem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.40 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
20 Feb 2024 | Others | ₹4.00 M | Open |
How Many Employees Work at Khard Biochem?
Unlock and access historical data on people associated with Khard Biochem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Khard Biochem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Khard Biochem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.